Company news
ImmuCell Corporation news in 2022
ImmuCell Corporation's news releases, calls and decks from 2022, newest first.
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2022
November 20, 2022
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2022
November 9, 2022
ImmuCell Announces Preliminary, Unaudited Sales Results for Third Quarter of 2022
October 4, 2022
ImmuCell to Participate in the Lytham Partners Fall 2022 Investor Conference
September 13, 2022
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2022
August 10, 2022
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2022
August 3, 2022
ImmuCell Receives Technical Section Incomplete Letter from FDA Pertaining to Re-Tain®
July 26, 2022
ImmuCell Announces Preliminary, Unaudited Sales Results for Second Quarter of 2022
July 6, 2022
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2022
May 11, 2022
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2022
May 9, 2022
Dr. Mark Wustenberg joins ImmuCell as Commercial Leader of Stakeholder Engagement
May 4, 2022
ImmuCell Announces Record Preliminary, Unaudited Sales Results for First Quarter of 2022
April 10, 2022
ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2021
February 21, 2022
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2021
February 15, 2022
ImmuCell Announces Record Preliminary, Unaudited Sales Results for the Year Ended December 31, 2021
January 4, 2022
Calls in 2022
Decks in 2022
- Investor Presentation (August 2022)
Investor deck · 52 slides · August 2022